Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@MarcJacksonLA 12
@JRMKE3 9
@Tickeron 6
@dhovekamp42 5
@Ba4Saso 4

Recent Tweets for FATE

bonjour247 @bonjour247
$FATE a @CathieDWood name.. about to enter the "Price-Volume Vacuum" (tm) .. Street love humping here, but I dunno,… https://t.co/lgGXJInDwo
May 8th 2021, 1:05pm
weston_psych @weston_psych
@Biotech2k1 $Fate has more data coming next week and given the platform, lower cost to manufacture off the shelf an… https://t.co/lAyBhlxKbv
May 8th 2021, 10:05am
weston_psych @weston_psych
@Biotech2k1 Thoughts on $fate?
May 8th 2021, 10:05am
JRMKE3 @JRMKE3
$FATE BlackRock added 492K shares in 1Q. Over 7.163M total!
May 8th 2021, 1:05am
MarcJacksonLA @MarcJacksonLA
$FATE Wedbush Upgrades Fate Therapeutics To Outperform From Neutral, $88 PT https://t.co/0as1obZXkQ
May 7th 2021, 4:05pm
ResearchPool @ResearchPool
$FATE #Fate Therapeutics Inc FATE Eyes ASGCT For Data Update: [...] https://t.co/FPdUQUsuse #equity #stocks https://t.co/nFz72QDfkm
May 7th 2021, 1:05pm
ResearchPool @ResearchPool
$FATE #Fate Therapeutics Inc FATE Eyes ASGCT: [...] https://t.co/m4R4ZDxCAk #equity #stocks https://t.co/3PuW3cmsdC
May 7th 2021, 2:05am
rolf_widerhofer @rolf_widerhofer
@bradloncar It only says $FATE is on the right track... and far ahead
May 6th 2021, 10:05pm
CSIMarket @CSIMarket
$FATE #StockMarket #FateTherapeutics published fiscal first quarter of 2021 Eps on https://t.co/savSNTKlN1: FATE an… https://t.co/KEBdT28rfk
May 6th 2021, 9:05pm
TheFalconDive @TheFalconDive
How's $VUZI market cap not above $FATE market cap by now???
May 6th 2021, 8:05pm
Gambiste1 @Gambiste1
RT @TradeCowboy: @XBI_guy Dr Miller works with both $FATE and $GTBP. Potential takeover candidate?
May 6th 2021, 5:05pm
TradeCowboy @TradeCowboy
@XBI_guy Dr Miller works with both $FATE and $GTBP. Potential takeover candidate?
May 6th 2021, 5:05pm
MarcJacksonLA @MarcJacksonLA
$FATE Jefferies Maintains Buy Rating On Fate Therapeutics, $145 PT https://t.co/Uus726P4Lj
May 6th 2021, 4:05pm
EarningsAlley @EarningsAlley
Fate Therapeutics, Inc. $FATE held an earnings call on 5/5/2021. Here are the highlights:
May 6th 2021, 3:05pm
MarcJacksonLA @MarcJacksonLA
$FATE Mizuho Securities Assigns A Buy Rating on Fate Therapeutics, $109 PT https://t.co/D3LBvM8DUC
May 6th 2021, 2:05pm
MarcJacksonLA @MarcJacksonLA
$FATE Oppenheimer Maintains Buy Rating On Fate Therapeutics, $135 PT https://t.co/5ooyGyaYv5
May 6th 2021, 2:05pm
Ba4Saso @Ba4Saso
$FATE waiting for buy signal https://t.co/tV6akReMUz
May 6th 2021, 1:05pm
JanEhses @JanEhses
Just listened to $FATE Q1 CC. ? Time to start focussing on certain indications me thinks....very all over the place… https://t.co/3hcubzRLow
May 6th 2021, 12:05pm
dhovekamp42 @dhovekamp42
@DrPaulyDeSantis $FATE great pioneering INDs for iPSC derived therapies but I guess if continued $ADAP will be firs… https://t.co/1UnDwhBGyf
May 6th 2021, 10:05am
dhovekamp42 @dhovekamp42
@davidal156 Too bad that $FATE CSO resigned before the meeting at this panel - missed his view here
May 6th 2021, 9:05am
Gambiste1 @Gambiste1
RT @DrPaulyDeSantis: $FATE speaks as if they never plan to file for approval, no clear regulatory strategy, dose escalations going slow and…
May 6th 2021, 8:05am
Tickeron @Tickeron
$FATE reports Earnings today. $FATE in Downtrend: Stochastic indicator peaks and leaves overbought zone. View odds… https://t.co/Z2drwPKpMJ
May 6th 2021, 7:05am
SiteFocusHQ @SiteFocusHQ
$FATE Earnings Intelligence Analysis of recent earnings identified Fate Therapeutics, Inc (NASDAQ: FATE ) business… https://t.co/BiajdFu0Oz
May 6th 2021, 4:05am
SeekingAlpha @SeekingAlpha
$FATE - Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q1 2021 Results - Earnings Call Transcript.… https://t.co/yWUwgIQ9n7
May 6th 2021, 3:05am
Gambiste1 @Gambiste1
RT @deepak31987414: $FATE I don't understand why somebody wants to loose a million on 95 strike calls. It should go beyond 100$ by May 21st…
May 6th 2021, 1:05am
WALLSTREETODDS_ @WALLSTREETODDS_
$FATE Out of the 272 other times FATE was down 6.2% during a trading day, 63% of the time it traded higher by the… https://t.co/fTXWWvM1j4
May 6th 2021, 1:05am
EdgarInsider @EdgarInsider
Alert [Press/News Current Report] / Form 8-K filed with the SEC $FATE FATE THERAPEUTICS INC https://t.co/qI9BbA1s0t
May 6th 2021, 1:05am
deepak31987414 @deepak31987414
$FATE I don't understand why somebody wants to loose a million on 95 strike calls. It should go beyond 100$ by May… https://t.co/1yiOBKt85W
May 6th 2021, 1:05am
Ba4Saso @Ba4Saso
$FATE waiting for buy signal https://t.co/NrEb9Qk47X
May 6th 2021, 12:05am
EdgarInsider @EdgarInsider
SEC Form 10-Q [Quarterly Report] filed by $FATE FATE THERAPEUTICS INC https://t.co/YJPeToKWOP
May 5th 2021, 10:05pm
Beeken_health @Beeken_health
$FATE - Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates https://t.co/uZUursIeRH https://t.co/IGJrzOsQXW
May 5th 2021, 10:05pm
Briefingcom @Briefingcom
$FATE: Fate Therapeutics misses by $0.05, beats on revs https://t.co/V8qApr5qAq
May 5th 2021, 10:05pm
DrPaulyDeSantis @DrPaulyDeSantis
$FATE speaks as if they never plan to file for approval, no clear regulatory strategy, dose escalations going slow… https://t.co/Hdpb4bPOtn
May 5th 2021, 9:05pm
mediasentiment @mediasentiment
$FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1029
May 5th 2021, 8:05pm
princetongb @princetongb
$FATE keeps piling up IND approvals. Preparing to present additional results May 13 during investor presentation.
May 5th 2021, 8:05pm
Estimize @Estimize
The most accurate $FATE estimate is from Cantor_22, beating 8 other analysts and the Wall Street Consensus - https://t.co/GZgwFBeGed
May 5th 2021, 8:05pm
Estimize @Estimize
$FATE reports inline with the Estimize EPS Consensus and beats the Estimize Revenue Consensus by $4.48M. Reports FQ… https://t.co/oQ7eg3tMP0
May 5th 2021, 8:05pm
Estimize @Estimize
$FATE reports FQ1 earnings of -48c EPS and $11.14M Revs - https://t.co/OlBdGVAPib
May 5th 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$FATE Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress https://t.co/Vw3G2AWius
May 5th 2021, 8:05pm
The_Ravid @The_Ravid
$FATE @FateThx next time, please don't sneak a trial failure into an earnings PR like you did today with acute GVHD… https://t.co/0XgEc42tw4
May 5th 2021, 8:05pm
Biotech2k1 @Biotech2k1
Hidden in $FATE's we are so awesome with iPSC presentation is the #fail of its phase 2 ProTimmune program for GvHD… https://t.co/CCnTjqxzZ8
May 5th 2021, 8:05pm
mediasentiment @mediasentiment
$FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 884
May 5th 2021, 8:05pm
mediasentiment @mediasentiment
$FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 883
May 5th 2021, 8:05pm
fintel_io @fintel_io
$FATE / Fate Therapeutics files form 10-Q https://t.co/3zm0SL9R4h
May 5th 2021, 8:05pm
princetongb @princetongb
$FATE https://t.co/SCttXYhqLO
May 5th 2021, 8:05pm
glitchbotio @glitchbotio
RT @MarketCurrents: $FATE - Fate Therapeutics EPS misses by $0.05, beats on revenue https://t.co/ie2lVTGlO1
May 5th 2021, 8:05pm
MarketCurrents @MarketCurrents
$FATE - Fate Therapeutics EPS misses by $0.05, beats on revenue https://t.co/ie2lVTGlO1
May 5th 2021, 8:05pm
FlashAlert_me @FlashAlert_me
$FATE [15s. delayed]: Issued Press Release on May 05, 16:01:00: Fate Therapeutics Reports First Quarter 2021 Financ… https://t.co/8KyT1EIjRR
May 5th 2021, 8:05pm
FlashAlert_me @FlashAlert_me
$FATE [15s. delayed] filed form 8-K on May 05, 16:01:27: Item2.02: Results of Operations & Financial Condition https://t.co/mecXk54Bjn
May 5th 2021, 8:05pm
fintel_io @fintel_io
$FATE / Fate Therapeutics files form 8-K - Financial Statements and Exhibits, Results of Operations and Financial C… https://t.co/l1getbDdbP
May 5th 2021, 8:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.